Groundbreaking, minimally invasive procedure means dialysis in half the time for late stage renal failure patient TINLEY PARK, Ill.–(BUSINESS WIRE)–Vascular Specialists in Tinley Park, Illinois, is pleased to announce that Dr. Eugene Tanquilut, has successfully completed the first Ellipsys Vascular Access System procedure in the Chicago Southland region. “Peter Song was a perfect candidate […]
Other News
Preclinical Studies Reveal Balloon-Based Drug Delivery to Be Critically Dependent on Coating Micro-Morphology, Suggesting a Paradigm for Accelerated Treatment Optimization
“These preclinical studies transform our understanding of how drug coated balloons deliver drug to the artery and why there is no class effect, while also providing tools for understanding the role of tissue stiffening with disease. The combination of mechanistic insight with predictive modeling can help accelerate development of new […]
AngioDynamics Reports Fiscal 2021 First Quarter Financial Results
Fiscal 2021 First Quarter Highlights Net sales of $70.2 million increased 6.3% compared to the prior-year quarter, inclusive of the previously disclosed $5.2 million order from the National Health Service (NHS) in the UK Gross margin declined 700 basis points year over year to 50.9% GAAP loss per share of […]
Saranas Awarded Technology Breakthroughs Contract With Premier
HOUSTON–(BUSINESS WIRE)–Saranas, Inc., developer of the Early Bird® Bleed Monitoring System designed for early detection of internal bleed complications during endovascular procedures, has been awarded a group purchasing agreement with Premier Inc., as part of Premier’s Technology Breakthroughs program. This new agreement, effective November 1, 2020, will allow Premier’s network of […]
Osprey Receives Supplier Horizon Award from Premier Inc.
Key Highlights Osprey Medical has been selected as a Supplier Horizon Award recipient by Premier Inc. Osprey is one of nine suppliers to win the prestigious award, and is the only cardiovascular supplier to receive the award this year Award validates Osprey’s customer service and engagement, value creation and commitment […]
Cardiac Dimensions Announces $17.5 Million Series C Financing to Accelerate Sales Expansion of The Carillon Mitral Contour System®
KIRKLAND, Wash., Sept. 29, 2020 /PRNewswire/ — Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, today announced the company has closed a $17.5 million Series C financing. All existing shareholders participated in the round including Aperture Venture Partners, Arboretum Ventures, Hostplus, […]
BioCardia Issued New Patent for Delivery of Cardiac Cell Therapy Through Wrist Artery
Technology May Enable Same-Day Outpatient Cell Therapy Procedures SAN CARLOS, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA] a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the issuance of U.S. Patent No: 10,780,248 for a “Radial and Transendocardial Delivery Catheter” that further protects the Helix™ […]
Biotricity Accelerates Shift to Remote Monitoring with Bioflux® Direct Program
New offering assists physicians by delivering Bioflux devices directly to at-risk patients, helping them avoid in-office visits REDWOOD CITY, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the launch of its Bioflux® Direct Program. The new offering ships Bioflux devices […]
Esperion Launches U.S. Direct-to-Consumer Campaign to Accelerate Awareness of NEXLETOL® (bempedoic acid) Tablets and Increase Awareness of Bad Cholesterol
ANN ARBOR, Mich., Sept. 28, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced the launch of “Break the Cycle with NEXLETOL”, a national direct-to-consumer (DTC) campaign aimed at broadening awareness of NEXLETOL® (bempedoic acid) Tablets and the never-ending patient cycle of diet, exercise and a statin treatment without ever […]
Aziyo Biologics Announces Appointment of Chief Financial Officer
SILVER SPRING, Md., Sept. 28, 2020 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced today that Matthew Ferguson has been appointed Chief Financial Officer (CFO), effective immediately. “We are […]



